E Good News From The Oil Patch And South Africa

Roche next Tuesday either gets or doesn't get the FDA's permission to market Avastin plus chemotherapy for advanced ovarian cancer for which there aren't many options. RHHBY is Swiss.

My old song was never trade Teva on Friday (when Tel Aviv is shut) but the new version is never trade Teva on Thursday because you have to wait until Monday to trade again. TEVA fell 1.11% yesterday.

Australian Orocobre posted a booster set of films about how it is the only ASX-listed high-grade lithium producer. Unfortunately among the recent Schwab horrors has been denying me access to my main holdings which are in ORL-Toronto because I bought before the ADR, OROCF, was created. I think the CEO who is about to retire should work on getting a better ADR than one which only works when Sydney is sleeping. Its mines are also in our hemisphere, in Argentina.

Finance and Banking

Hargreaves Lansdown in London wrote up the favorable reactions there to the takeover of Virgin Money by Clydesdale & Yorkshire Banking Group: Challenger bank CYBG topped a sinking London market after its merger with Virgin Money won the blessing of City analysts who declared that it will finally create a “national competitor” to break the big four lenders’ stranglehold. CYBG and Virgin Money’s £1.7 billion all-share tie-up is the latest in a wave of challenger bank consolidation deals amid climbing costs and fierce competition. than two drunks propping each other up at a bar,Panmure Gordon argued in an upgrade to buy that the cost savings will 'significantly improve profitability'. A full product range offered by the combined entity will make it a national competitor to its larger rivals. JP Morgan backed CYBG boss Debbie Crosbie’s claim that a merger will create a 'proper' challenge to the big four because VM's’s mortgage and credit card customers would complement CYBG’s specialism in current accounts and small business banking.” I had no idea that CYBG is also a woman-headed bank. 

Good old Schwab has now imposed a $50 fee for trading this pink sheet stock, another reason to hold on while the ducks line up in a row. 

Another signed seekingalpha.com article by Khen Elazar supported buying slowly into Banco Santander whose recovery from the global financial crisis is proceeding as a dividend growth stock. Unfortunately my Schwab account keeps sending me news about Sanofi when I type in SAN, which unfortunately is the French ticker symbol for the drug firm. There is no excuse as NYSE-SAN is the ticker symbol of the stock I own. SAN is up 0.75% today on the bouncy European purchasing manager's index which hit 54.8 in June while the US one hit $56.5. Any number over 50 means growth, and this is a very big number by PMI standards. Note that sub SAN Consumer USA Holdings has seen insider selling reported to the SEC by SC.

For some reason Aberdeen Emerging Markets Equity & Income Fund subscribed to a fraud protection policy worth $100,000 for any single loss and a total of $1 million with UK insurer Willis Towers Watson Ltd, a related company. It covers stop payment orders, uncollectible deposits, audit expenses, unauthorized signatures, and telephone fraud by customers or staff. The closed-end fund just concluded a buyback which was heavily over-subscribed. 

View single page >> |

Disclosure: None. Subscribe to Global-Investing for more updates.

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Gary Anderson 1 year ago Contributor's comment

We hope gaslighting is just a hobby of POTUS and not a sign of a diabolical desire to be king.

Bill Myers 1 year ago Member's comment

Well said.